View All Conferences
American Academy of Dermatology 2015 Annual Meeting
The American Academy of Dermatology 2015 Annual Meeting will feature the latest research and information on a wide array of topics in the practice of dermatologic medicine.
Treatment of Plaque Psoriasis Taking Big Steps Forward Part 2
While several new treatment options for plaque psoriasis and psoriatic arthritis have launched in recent years, there is still much work to be done in the field to help patients through long stretches of care.
Treatment of Plaque Psoriasis Taking Big Steps Forward
The array of medications and treatments for plaque psoriasis and psoriatic arthritis continues to expand, giving doctors and patients more choices when deciding on a management plan.
New Medication Shows Early Promise for Psoriasis Patients Part 2
A lot of work goes into a medication being approved for the public including many rounds of trials and adjustments along the way. For a new plaque psoriasis medication that work is well underway and the developers hope to have it to patients in the near future.
New Medication Shows Early Promise for Psoriasis Patients
The development of new medications to help patients with plaque psoriasis seems to take steps forward on a daily basis. Results presented at a recent conference showed at least one could help provide much needed relief for this patient group.
Fine Line Between Clear and Almost Clear Psoriasis Severity
Understanding the difference between clear and almost clear skin is crucial with the advent of new biologic therapies that make complete clearance attainable.
Biologics & Psoriasis: Medicare Patients
Psoriasis treatment in the geriatric demographic has long been poorly understood.
Investigating Melanoma Rates in Asian and Hispanic Populations
Whether it is sitting at the beach, working in the yard or just walking to the grocery store, the risk of developing skin cancer is a risk for everyone. A recent study looked at the impact of the sun particularly for asian and hispanic people.
Diagnosing Vitiligo Runs More Than Skin Deep Part 2
The treatment of vitiligo has come a long way in recent years and there is already work being done to improve treatment in the future.
Diagnosing Vitiligo Runs More Than Skin Deep
When treating a patient with vitiligo it can be easy to look at their skin condition and no further. There is work being done to show that more can be done to help the patient not only physically, but mentally as well.
Favorable Results from Dermira's DRM01 Acne Program
Dermira, Inc. presented clinical data from its successful DRM01 Phase 2a trial in patients with facial acne vulgaris at the American Academy of Dermatology (AAD) Annual Meeting on March 20, 2015 in San Francisco.
New Test Could Clear Up Some Melanoma Diagnoses
In most instances a microscope is enough to make a diagnosis of melanoma, but in some the view under the lens does not provide a clear enough picture. A new test that combines math and science could make the most difficult cases easier to identify.
Shingles Vaccine Provides Benefits Without Much Risk
For anyone who has had or been exposed to someone with chicken pox herpes zoster, or shingles, can be a very real risk. A vaccine for patients over the age of 60 can greatly reduce the likelihood of contracting the disease.
Melanoma Care Highlights Busy Schedule at AAD 2015
The American Academy of Dermatology is meeting in San Francisco and while there are many noteworthy topics being discussed, melanoma is one of the leading topics of discussion at the event.
Plaque Psoriasis: Cosentyx Continues to Come Out on Top
Novartis announced results from the CLEAR study demonstrating Cosentyxâ„¢ (secukinumab) improved skin clearance at Week 16 in significantly more moderate-to-severe plaque psoriasis patients compared to Stelara®* (ustekinumab), a widely used biologic.
Latino Patients with MS Struggle with Depression, Fewer Resources
Can Nurse Practitioners Fill the Void in Primary Care?
Women Who Clean More Likely to Develop Asthma, Lung Function Decline
Nusinersen Reports Multiple Motor System, Survival Benefits for Spinal Muscular Atrophy
FDA OKs Tolvaptan, First Treatment to Slow Kidney Function Decline
Affordable Care Act
PHYSICIAN'S MONEY DIGEST >
MD Magazine Resources
Terms & Conditions
Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.